Efficacy of a combination of idarubicin, etoposide and intermediate-dose cytosine arabinoside as salvage therapy in relapsing or resistant unfavorable lymphoma.
about
Efficacy of a combination of idarubicin, etoposide and intermediate-dose cytosine arabinoside as salvage therapy in relapsing or resistant unfavorable lymphoma.
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Efficacy of a combination of i ...... esistant unfavorable lymphoma.
@ast
Efficacy of a combination of i ...... esistant unfavorable lymphoma.
@en
type
label
Efficacy of a combination of i ...... esistant unfavorable lymphoma.
@ast
Efficacy of a combination of i ...... esistant unfavorable lymphoma.
@en
prefLabel
Efficacy of a combination of i ...... esistant unfavorable lymphoma.
@ast
Efficacy of a combination of i ...... esistant unfavorable lymphoma.
@en
P2093
P1433
P1476
Efficacy of a combination of i ...... resistant unfavorable lymphoma
@en
P2093
Bernasconi C
Brusamolino E
Castagnola C
Lazzarino M
Pagnucco G
P304
P577
1998-04-01T00:00:00Z